To estimate the number of fallers and risk factors for falls in a cohort with dementia, we did a secondary analysis of a cluster-randomized controlled trial (NutriAlz) in 11 outpatient and day care centers in Catalonia (Spain) including 626 communitydwelling patients with dementia, followed for 12 months. Participants' characteristics were assessed at baseline, at 6 and 12 months [fall in the earlier 6 mo, anthropometric data, comorbidities, Mini-Mental State Examination, Clinical Dementia Rating, Basic Activities of Daily Living (BADL), Instrumental Activities of Daily Living, Neuropsychiatric Inventory Questionnaire, Zarit Caregiver Burden Interview and Mini-Nutritional Assessment]. Multivariate logistic regression models and generalized linear models were used to explore risk factors for falls and changes in health and function. Two hundred twenty-three participants fell during the 12 months follow-up (35.62%). Risk factors identified for falls were age (odds ratio (OR)=1.03, 95% confidence interval (CI), 1.00-1.05), BADL (OR=1.18, 95% CI, 1.05-1.32), and earlier fall (OR=2.30, 95% CI, 1.57-3.35). Fallers had worse health than nonfallers, and their dependence increased significantly more in BADL during the study, compared with nonfallers. Dependence in BADL is a risk factor and a consequence of falls; interventions aimed at preventing falls in dementia patients could promote autonomy in BADL and slow its decline.
F alls are common in older adults and can have undesirable consequences such as injuries, fractures, loss of mobility, or decline in the activities of daily living. Older people with cognitive impairment are more likely to suffer falls. 1, 2 In an earlier study, risk of falls in a community sample with mild/moderate dementia was approximately 42%. 3 In addition, patients with cognitive impairment and dementia have a poorer prognosis once a fall has occurred. Compared with demented older adults who do not fall, fallers have a higher risk of functional decline and are approximately 5 times more likely to be institutionalized. 4 Consequently, medical expenditure increases, as use of care and costs in Alzheimer dementia (AD) are significantly associated with worse cognition, worse function, and higher comorbidity. 5 Given the associated morbidity, psychosocial consequences and costs of falls, their prevention is a major topic of interest, and it is still unresolved. Several factors have been postulated as risk factors for falls in this population, such as aging, history of falls, motor impairment, visual disturbance, cognitive dysfunction, behavioral disturbances, or use of neuroleptics. Potentially modifiable factors are the target of preventive interventions, which have shown uncertain effectiveness. Although some interventions have proved to be effective in preventing falls in older people living in the community, 6 this evidence may not be generalizable to older people with dementia, as a majority of studies have specifically excluded them from participation or cognition status was not stated. 6, 7 In contrast, evidence on the effectiveness of fall prevention programs in cognitively impaired participants is based mostly on institutionalized populations. [8] [9] [10] [11] [12] Interventions should address potentially modifiable predictors of falls in community dwelling individuals with dementia. Better understanding of the risk factors for falls will allow researchers to devise more efficacious and suitable fall prevention programs. The NutriAlz trial offers a unique possibility to investigate these aspects, as it represents the largest to date clinical trial on community-dwelling older adults with dementia. The aims of the present analysis are: to estimate the number of fallers and to identify risk factors for falls in a cohort of noninstitutionalized individuals with dementia followed for 12 months, and to compare the changes in health and functional status during the follow-up period between fallers and nonfallers.
METHODS

Population
This study is a secondary analysis of NutriAlz, a clusterrandomized clinical trial done in 11 centers in the region of Catalonia (Spain), comparing a health and nutrition promotion program versus usual care in a cohort of noninstitutionalized individuals with diagnosed dementia. The trial methods, conduct, and baseline characteristics have been described earlier. 13 The NutriAlz trial randomized 946 patients, to be assessed at baseline, 6 months (first visit), and 12 months (last visit). The population for our main analysis is constituted by the 626 patients that had complete follow-up (completers), and subanalyses were carried out to compare them with the noncompleters (320 noncompleters: 206 dropped out before the first visit and 114 dropped out before the last visit). Participants and/or their main caregiver were asked "Has the individual fallen in the previous 6 months?" Thus, the memory recall period of falls was 6 months. We have labeled as fallers the people answering positively to this question in at least 1 study visit.
Statistical Analysis
To explore the association between a list of potential risk factors for falling and the occurrence of falls, univariate analyses were carried out by means of w 2 tests for categorical variables and t tests for continuous variables. A number of socio-demographic, anthropometric, neurological, and comorbid assessments were considered in the univariate analyses: sex, age, history of earlier fall(s), years since the beginning of symptoms and since the diagnosis of dementia, type of dementia, living arrangement, body mass index (BMI), parkinsonism, dysphagia, aphasia, dysarthria, spasticity, weakness, Charlson index, 14, 15 heart attack, heart failure, diabetes, fractures, arthritis, back problems, peripheral arterial disease, hemiplegia, cardiovascular disease, depression, hypertension, sight problems, and hearing problems. Use of haloperidol, atypical antipsychotics, benzodiazepines, antidepressants, memantine, donepezil, galantamine, and rivastigmine was also considered. Health status, functional status, and burden of disease measures included the Mini-Mental State Examination (MMSE), 16 Clinical Dementia Rating (CDR), 17 Basic Activities of Daily Living scale (BADL), 18 Instrumental Activities of Daily Living scale (IADL), 19 Neuropsychiatric Inventory Questionnaire (NPI-Q) number of symptoms/severity/ stress, 20, 21 Zarit Caregiver Burden Interview, 22 Cornell scale, 23 and Mini-Nutritional Assessment (MNA). 24 A multivariate backward stepwise logistic regression model was built with variables that were significantly associated with falls in the univariate analyses and had a minimum frequency of 5%. Selection of variables in the multivariate model was based on the likelihood ratio test P values (0.05 for entry, 0.1 for removal). The final model was checked for consistency, using different strategies for model building (either starting with a saturated model and deleting one variable at a time, or building the model with a stepwise forward approach). When similar scales showed collinearity, the ones that were less meaningful or introduced more instability into the model were excluded.
To explore and compare clinical evolution during the study period between fallers and nonfallers, a generalized linear model was built for each clinical scale assessed. All models had the same structure: a within-patient effect defined by scale mean values at baseline, first and last visit; a between-patients effect defined by covariate "fall during the study;" and an interaction term between both factors. These models allow exploration of several questions: whether scale values change during the study, whether fallers present mean scale values different from nonfallers, and whether evolution during the study of scale values differs between fallers and nonfallers. Analysis was carried out using PASW Statistics, version 18.0.0 (SPSS).
RESULTS
Main descriptive and statistical results of univariate analyses are shown in Tables 1 and 2.
Number of Fallers
Across the 12 months follow-up, 223 of 626 individuals (35.62%) experienced at least 1 fall. The likelihood of falling was significantly higher for the individuals who had fallen in the year preceding the study than for those who had not (w 2 P<0.001). The number of fallers was different among the study sites (range, 12.5% to 54.5%, w 2 P<0.001), because of the case mix of participants attending each center.
Baseline Risk Factors for Falls
In the univariate analysis, fallers were more likely to have a history of falls in the previous year and to present weakness, cerebrovascular disease, and arthritis, compared with nonfallers. In addition, fallers had a worse mental, functional, and nutritional status, as shown by significant differences in MMSE, CDR, BADL, IADL (number of activities with difficulties), NPI-Q (number of symptoms, severity, and distress), Cornell, and MNA.
Potential risk factors entered into a multivariate regression model were age, MMSE, CDR, BADL, number of symptoms in NPI-Q, Cornell, MNA, weakness, arthritis, cerebrovascular disease, previous fall, mixed dementia, and participant center. Redundant variables were not included in the model: severity and stress of NPI-Q were collinear with number of symptoms in NPI-Q, whereas IADL was collinear with MMSE, CDR, and BADL and introduced instability in the model. Mixed dementia was added to the model because of its clinical relevance, regardless of nonsignificance in the univariate analysis.
The final model kept 3 variables as independently associated with falls (age, BADL scale, history of previous fall), adjusted by the study site ( Table 3 ). The risk of falling increases with increasing age: for each 5 years increase in age, the odds of falling show a 10% increase. A history of falls during the previous year doubles the odds of falling. For each additional BADL with dependence, the odds of falling increase approximately 15%. The adjustment by participant's study site has a dual goal: on the one hand, to take into account the differences in the population treated and recruited in the different centers, and in contrast to consider the effect of cluster randomization.
Changes in Health and Functional Status in Relation to Falls
The results for the generalized linear model are shown in Table 4 . All the considered measures (MMSE, CDR, BADL, IADL, NPI-Q, Zarit, MNA, and BMI) showed a significant worsening during the follow-up (baseline, first, and last visit). Exceptions were NPI-Q subscales (number of symptoms, severity, and distress), which showed an improvement over time, with better results at last visit than at baseline. Fallers, compared with nonfallers, had worse results in all the considered domains, both at baseline and at the last visit. Differences were significant or marginally significant for all the measures, except BMI and the caregiver burden (Zarit) . Nevertheless, clinically meaningful differences were only observed at the last visit for MMSE (2 points), BADL (1 activity), and NPI-Q (1 symptom, 2 points in severity, and 3 points in distress).
The interaction term showed that differences in scale values between fallers and nonfallers were constant during the study for all scales except BADL and CDR. For these latter scales, fallers show a more pronounced decline during the study than nonfallers. Decline in the BADL scale during the study was 42% for fallers versus 40% in nonfallers, ending with dependence in 4 and 3 basic activities of daily living, respectively. Decline in CDR was 22% in fallers and 19% in nonfallers.
Sensitivity Analysis: Comparison With Noncompleters
For the 320 people that presented a premature withdrawal, reasons for not completing all assessments were: move to an institution (28.12%), death (22.5%), lost contact (3.75%), medical complications (8.13%), no will to participate (8.75%), temporarily missing (9.37%), other (19.38%). Completers were less likely to report falls earlier to the study entry (N=626, 32.3%) than either of the noncompleter subpopulations (N=206, 46.1%; N=114, 44.7%) ( Table 5 ). In addition, completers were less likely to fall during the first half of the trial (N=626, 20.2%) than participants that dropped out after the first visit (N=114, 32.5%).
Of particular interest is the noncompleter subpopulation of individuals that left the study after the first visit (minimum follow-up of 6 mo). This population presented a distribution similar by sex, age, and type of dementia to the completer population, although noncompleters presented more advanced dementia as measured by MMSE and CDR, and significantly more cases of Lewy bodies and less cases with vascular dementia. Descriptive baseline results for main scales and comorbidities are presented in Table 6 for both populations. Unsurprisingly, the overall completers subpopulation presents better health and functional status than the drop-out subpopulation, as measured by the clinical scales. These 2 subpopulations were similar with respect to main clinical comorbidities and neurological outcomes, presenting only significant differences in prevalence of Parkinson, weakness, dysphagia, and chronic respiratory disease. Noticeably, noncompleters showed a lower prevalence of fracture/joint prosthesis.
Sensitivity Analysis: Risk Factors for Fall at 6 Months (First Visit)
The sensitivity analysis of the risk factors for fall at the first visit included 740 individuals, 163 of whom fell during this period (22%). The univariate analysis identified those risk factors for fall already identified on the completers analysis (except NPI-Q number of symptoms and arthritis), and a number of additional risk factors (years with diagnosis of dementia, brachial circumference, fracture, sight problems, parkinsonism, spasticity, dysphagia, aphasia). A multivariate logistic regression model built with these factors kept as significant the variables age, BADL, earlier fall, and NPI-Q severity. Thus, this multivariate model was congruent with the model built for predicting falls during 12 months, with the addition of NPI-Q severity.
DISCUSSION
In this study we have found that more than a third of study participants followed during 12 months fell during that period (223 of 626, 35.62%). Risk factors for falls are age (odds of fall increase by 10% for every 5 y of age), BADL scale (15% odds increase for each additional BADL with dependence), and fall earlier to study entry (100% odds increase). In particular, not only dependence in BADL was higher in fallers than in nonfallers, but also the magnitude of the differences increased during the study, as opposed to other clinical measures. Dependence in BADL is the only modifiable risk factor identified in this review. Sadly, although clinical guidelines 25, 26 recommend that care plans address activities of daily living to promote independence, little research has been carried on to assess which specific interventions are beneficial. There is limited evidence from randomized clinical trials showing the efficacy of intervention programs on ADL 27, 28 and physical exercise 29, 30 in maintaining functional ability, and only 1 of these trials focused on community-dwelling patients. 28 The percentage of fallers estimated in this trial is notably lower than in other trials, 3, 31 possibly because of the types of dementia included in the case mix. The inclusion criteria of the NutriAlz trial were deliberately nonrestrictive, with the aim that the study participants accurately mirror the epidemiological case mix of people attending clinical centers for dementia. Participants presented mainly with AD (65%), vascular dementia (13%), or a combination of both types of dementia (14%), adding to 92% of the cases. Particularly, striking is the scarce presence of cases of Lewy body dementia (8 cases) and Parkinson dementia (2 cases), which are associated with a higher risk of falls than other types of dementia. 32, 33 Differences with other studies in percentage of fallers were reduced sensibly when comparing equal types of dementia. In this trial, percentages were 35.8% in AD, 30.9% in vascular dementia, and 42.2% in mixed Alzheimer-vascular dementia. Incidence for community samples with AD ranges from 42.3% to 47%, 3, 31 whereas percentage for vascular subtypes is estimated at 47%. 31 The wide range of assessments in our trial covered most of the risk factors identified in earlier studies. A review of risk factors of falls identified in cohort or case-control trials in people with dementia 33 classified risk factors into 8 categories: disease-specific motor impairments, impaired vision, type and severity of dementia, behavioral disturbances, functional impairment, fall history, neuroleptics, and low bone mineral density. Other more specific factors have been cited, such as periventricular white matter lesions, 3 visuocognitive impairment, 32 or orthostatic hypotension. 31 Our study assessed most of these general categories, with the exception of pain, motor impairment and bone mineral density, and other hypothetic modifiable risk factors related to living arrangement characteristics (ie, surface of the floors or presence of stairs at home). Although our results confirm the importance of some risk categories such as history of falls and functional impairment assessed by the BADL scale, other risk categories were shown to be less related to falls than in earlier studies. In our trial, visual impairment, neuroleptics, and type of dementia were not significantly related to falls; this may be explained by the case mix, which included few people taking neuroleptics and very few people with Lewy bodies or Parkinson dementia. In addition, behavioral and psychological symptoms, assessed by NPI-Q, were related to falls in the univariate analysis but not in the multivariate analysis.
It is important to point out that fall risk "is influenced by type and severity of dementia, and by behavioral disturbances as accompanying symptoms of the illness." 33 Similarly, fall risk factors depend on type and severity of dementia. Behavioral impairments are a relevant factor in mild dementia, but its importance will lessen as dementia advances and less behavioral disturbances are observed. In addition, as dementia progresses and patients lose their mobility, fall risk decreases. In this study, most patients had AD, vascular dementia, or mixed vascular-Alzheimer dementia. Participants in this trial showed significant decline over time in activities of daily living (mean relative decline 41%, median relative decline 25%), slightly higher than what was observed in nursing home residents with moderate severity dementia (10% decline in activities of daily living during 6 mo). 34 The results of this trial are applicable to people with similar characteristics.
This study has several strengths, such as the sample's characteristics, including ambulatory community dwelling older adults with mild-to-moderate dementia. The followup period of 12 months is adequate to reliably assess falls and clinical changes. This is probably the largest clinical trial on falls in individuals with dementia, even when considering only completers followed during the entire year (N=626). The health assessments of participants were thorough and diverse, considering comorbidities and measures of depression, behavior, function, and cognitive impairment, and thus a wide range of potential risk factors were considered in the analysis.
In contrast, a number of limitations have to be taken into account. First, this randomized trial was not designed to prospectively assess the incidence of falls, and thus the methods implemented to assess falls could be improved, for example using fall diaries and monthly follow-up, which allow for estimation of incidence density ratios of falls. Retrospective collection of information on falls introduced a memory bias and a related misclassification bias, which may have resulted in an underestimation of fallers and repeated fallers, and an underestimation of differences between fallers and nonfallers.
As in similar trials focusing on the same population, attrition of participants was significant (32%), which is to be expected given the age and comorbidities of participants and the likely advance of dementia during the study period, which leads to institutionalization, death, or medical complications. The design of the study limited the valid analysis to individuals followed for the entire study (completers), which have a better health and performance status than the average population with dementia. From the results in Table 5 it can be seen that inclusion of noncompleters could increase the overall percentage of fallers in 10 percentage points, up to 45.6% at 12 months. In addition, it is possible that the risk factors identified in this study are only a few in a more extensive list, as the risk factors for the population followed for 6 months include but are not limited to the risk factors for the completers population.
In conclusion, in this sample of older adults with mildto-moderate dementia, primary prevention of falls may be even more important than secondary prevention, as an earlier fall seems to be a risk factor for further falls. In addition, dependence in BADL is not only a risk factor for falls, but also a consequence of them and can be worsened by falls. Interventions aiming to prevent falls in people with dementia might help the preservation of BADL independence and slow its decline over time. Future intervention studies should focus on prevention of falls through the correction of modifiable risk factors in community-dwelling individuals with mild/moderate dementia, and assess the efficacy of specific strategies to maintain functional independence.
